Robb Gary Charles sold CORT
May 13, 2026 · Form 4 insider transaction
Robb Gary Charles sold 5,300 shares of Corcept Therapeutics Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Includes 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, and 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Excludes 49,716 shares previously owned directly which were transferred to the Gary Charles Robb TTE Robb Revocable Trust.